Microspectrofluorometry of autofluorescence emission from human leukemic living cells under oxidative stress.
Image cytometry was applied to study the intracellular localization of autofluorescence and the influence of an oxidative stress on this emission. K562 erythroleukemia cancer cells were analyzed with a microspectrofluorometer, coupled with a Argon laser (Ar+) (363 nm). From each cell, 15 x 15 emission spectra were recorded in the 400-600 nm spectral range to generate a spectral image of autofluorescence. The intracellular locations of the autofluorescence emission and of the specific mitochondrial probe rhodamine 123 (R123) were matched. Under a 363 nm excitation, all spectra from K562 cells show equivalent profiles with a 455 nm maximum emission, near of reduced nicotinamide adenine dinucleotide-(Phosphate) solution (NAD(P)H) (465 nm maximum emission). The spatial distribution of autofluorescence is homogeneous and different from the one of R123. Hydrogen peroxide (H2O2) (200 microM) and menadione (Men) (5 microM) induce a weak spectral change and a decrease in autofluorescence intensity, down to 40% of the initial emission. Doxorubicin (Dox) induces a dose-dependent decrease in autofluorescence emission and a release of intracellular free radicals. When cells were pre-treated 1 h with 1 mM glutathione (GSH), Dox induces a lower free radicals release, no significant variation of autofluorescence intensity and a lower growth inhibitory effect. Images cytometry of autofluorescence suggest that the intracellular NAD(P)H would not be restricted to mitochondrial compartments. The release of free radicals was associated with a decrease in autofluorescence intensity, mainly attributed to NAD(P)H oxidation both inside and outside mitochondria.
Bondza-Kibangou
P
P
Laboratoire de Physiologie Cellulaire & Hématologie, UFR de Pharmacie, IFR 53, Unité Médian, CNRS FRE-2141, Reims, France.
Millot
C
C
Dufer
J
J
Millot
J M
JM
D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000494:pharmacology; D005453:Fluorescence; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D020014:K562 Cells / Q000737:chemistry* / Q000378:metabolism; D004915:Leukemia, Erythroblastic, Acute / Q000378:metabolism; D015591:Microspectrophotometry; D008928:Mitochondria / Q000737:chemistry; D009249:NADP / Q000378:metabolism; D016877:Oxidants / Q000494:pharmacology; D018384:Oxidative Stress; D013050:Spectrometry, Fluorescence; D024483:Vitamin K 3 / Q000494:pharmacology
D016877:Oxidants; D009249:NADP; D024483:Vitamin K 3; D004317:Doxorubicin; D006861:Hydrogen Peroxide